The Estimation of Economic Effectiveness of Preventive Measures of Non-Infectious Diseases

Abstract

Introduction: The world today is characterized by the globalization of processes affecting social development. The globalization of preventive work today necessarily involves inter-sectorial interaction. Such a huge work with the preventive aim allows to comprehensively influencing the positive effect on the prevention of negative manifestations in the health of both human and the whole population. That means, that we can talk about a preventive strategy, which should be inherent in total character. The Public Health Service should have a state approach. Many countries confirmed this, such as: USA, Sweden, France, Germany, Great Britain, etc. Prevention, in the broadest sense of the word, must take place, of course, both at the local level and at the interregionale one, and if we talk about a global approach, then we also can speak about the international level. The economic effect of such work is clearly demonstrated as a consequence of prophylactic programs on infectious diseases. The aim of this article is to justify the economic effectiveness of the prevention of non-communicable diseases and to determine the criteria for calculating the economic forecast. Materials and methods: The research was conducted with the help of theoretical and statistical methods, by studying scientific sources and systematic analysis and generalization of the experience of finding economic efficiency of preventive measures for non-communicable diseases. Review and conclusions: The analysis of the considered methods of economic evaluation of preventive measures of non-infectious diseases made it possible to draw the following conclusions, the effectiveness of the health care system and individual treatment and prevention institutions should be considered in a complex way from the point of view of medical, social and economic efficiency. Economic efficiency, as a rule, is the result of medical and social efficiency. When calculating the cost-effectiveness of treatment and prevention measures, the whole complex of losses and costs associated with illnesses should be taken into account, in particular: direct costs directly related to prevention and treatment; Indirect losses associated with the illness, due to the unprocessed part of the gross domestic product, paid by sick leave letters.

Oral Quercetin in Adult Patients as a Potential Nutraceutical against Coronavirus Disease 2019 (COVID-19)

“…COVID-19 causes more fatalities in patients with advanced chronological age [5], as reflected in our study where the highest proportion of affected is among those over 60 years of age, in terms of sex, we have not found any relevant difference.…”

“…In the fight against diseases and more when we speak of a pandemic, we have the option of starting a preventive or prophylactic treatment in order to reduce the incidence or severity of the disease and the public expenditure disease [5]. However, drug prophylaxis is still controversial, without considering the possible adverse effects in some cases such as hydroxychloroquine / chloroquine use of biochemicals is an alternative that is imposed in these cases as COVID chemoprophylaxis.…”

Research of the Actual Energy Consumption of the Military Personnel of the Armed Forces of Ukraine to Substantiate the Correction of Their Daily Diet

“…Energy costs and their adequate compensation are a significant indicator of the combat effectiveness of personnel [3,4]. The authors [5,6] pay special attention to the study of the issue of the energy needs of servicemen during the training process during the training of SOF. At the same time, the problem of compensation of the energy costs of military personnel, including SOF, in the armed forces of foreign countries remains not fully studied.…”

Changes in Biochemical Blood Values During Complex Treatment of Rhinosinusitis Polyposa Patients

“…In recent years, there has been a significant increase in the number of diseases of the nose and paranasal sinuses both in absolute figures and in percentage of the total number of ENT diseases [2,3]. The increasing number of patients with inflammatory diseases of the paranasal sinuses causes significant expenditures in the public health system associated with modern technologies of treatment, as well as using a large number of expensive drugs [2,4].…”